(Total Views: 108)
Posted On: 12/11/2019 6:02:35 AM
Post# of 12921
![Avatar](https://investorshangout.com/images/ProfileImages/734810790_1098_wst.png)
$PBIO's data from Analysis of Cancer Tissue Proteins Generated from Novel Workflow Could Lead to Improvement in the Clinical Management of Gynecological Cancers
Pressure BioSciences, Inc. , a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced the Company’s patented pressure cycling technology (“PCT”) platform was featured as an integral part of a new, innovative workflow for the analysis of proteins from cancer biopsy samples.
#stocks
Pressure BioSciences, Inc. , a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced the Company’s patented pressure cycling technology (“PCT”) platform was featured as an integral part of a new, innovative workflow for the analysis of proteins from cancer biopsy samples.
#stocks
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)